2nd Quarter - Report

DIALYSIS PATIENT CITIZENS for DIALYSIS PATIENT CITIZENS

Firm
Client
Income
—
Expenses
$500,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect organ donors by urging passage of the living donor legislation; Protect dialysis patient access to charitable premium assistance; Support ESRD care coordination; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support H.R. 5027/S. 4469 the Chronic Kidney Disease Improvement in Research and Treatment Act; Assist the Administration about prioritizing prevention of kidney disease and home dialysis; Support H.R. 6860 -The Restore Protections for Dialysis Patients Act to protect access to private insurance; Urge the Administration to provide adequate reimbursement to address the ongoing staffing shortages at dialysis centers; and Urge the Administration to provide appropriate reimbursement to increase dialysis patient access to new and innovative therapies. Urge passage of H.R. 5074/S. 4510 - The Kidney Patient Act that would delay the move of oral-only ESRD drugs into the ESRD bundle until 2033.

LobbyistCovered position, as disclosed
MEGAN BEVERIDGE HASHBARGER New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); White House Office

Bills named: H.R. 5074 (118th), S. 4510 (118th), H.R. 6860 (118th), H.R. 5027 (118th), S. 4469 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.